In this podcast, Michael Peters, MD, talks about his team's cross-sectional analysis on the use of blood eosinophils and IL-6 as predictive biomarkers of the exacerbation-prone asthma phenotype over 3 years. More at www.consultant360.com/pulmonology.

In this podcast, Michael Peters, MD, talks about his team's cross-sectional analysis on the use of blood eosinophils and IL-6 as predictive biomarkers of the exacerbation-prone asthma phenotype over 3 years. More at www.consultant360.com/pulmonology.

In this podcast, Michael Peters, MD, talks about his team's cross-sectional analysis on the use of&nbsp;blood eosinophils and IL-6 as predictive biomarkers of the exacerbation-prone asthma phenotype over 3 years. More at www.consultant360.com/pulmonology.

Michael Peters, MD, on IL-6 as a Biomarker for Asthma Exacerbations

Podcasts360, powered by Consultant360, features short interviews with medical professionals about current research, news, and general information for health care providers in 35+ specialties.

Share Michael Peters, MD, on IL-6 as a Biomarker for Asthma Exacerbations

Sign up to save your podcasts

Michael Peters, MD, on IL-6 as a Biomarker for Asthma Exacerbations

Michael Peters, MD, on IL-6 as a Biomarker for Asthma Exacerbations

More shows like Podcasts360

The Curbsiders Internal Medicine Podcast